CLEVELAND BIOLABS INC 5
5 · CLEVELAND BIOLABS INC · Filed Feb 17, 2015
Insider Transaction Report
Form 5
SALUCK RANDY S.
Director
Transactions
- Award
Stock Option (right to buy)
2014-06-11+1,750→ 1,750 totalExercise: $9.80From: 2014-06-11Exp: 2024-06-11→ Common Stock (1,750 underlying)
Footnotes (1)
- [F1]As adjusted for 20-to-1 reverse stock split, effective January 28, 2015.